![Aaron Ren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aaron Ren formerly worked at Sironax Ltd., as Chief Executive Officer & Director, MedImmune LLC, as Director-Business Development, and Viela Bio, Inc., as SVP, Head-Business Development & Operations.
Dr. Ren received his doctorate degree from the University of Washington and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
| Bedrijven | Functie | Einde |
|---|---|---|
| VIELA BIO, INC. | Operationeel Directeur | 31-12-2020 |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Directeur | - |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
Sironax Ltd.
Sironax Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
